Clinical Trial: A Multicenter, Open-label, Phase II Umbrella Study to Evaluate the Efficacy and Safety of the Investigational Product in Participants With Advanced or Metastatic Pancreatic Cancer

U.S., Sept. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07814066) titled 'A Multicenter, Open-label, Phase II Umbrella Study to Evaluate the Efficacy and Safety of the Investigational Product in Participants With Advanced or Metastatic Pancreatic Cancer' on Sept. 02.

Brief Summary: This is a multicenter, open-label, Phase II umbrella study conducted in participants with advanced or metastatic pancreatic cancer. This study has set up different cohorts to evaluate the efficacy and safety of multiple investigational products in pancreatic cancer.

Study Start Date: Oct. 31

Study Type: INTERVENTIONAL

Condition: Pancreatic Cancer

Intervention: DRUG: SKB571

q3w

Recruitment Status: NOT_YET_RECRUITING

Sp...